Literature DB >> 6127928

Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.

F I Polezhaev, L M Garmashova, T A Koval, G P Taranova, N V Topuriya, G I Aleksandrova.   

Abstract

Conditions of obtaining attenuated influenza virus recombinants by crossing of a cold-adapted donor with A (H1N1) influenza virus that reappeared in 1977 were studied. Temperature-sensitive recombinants suitable for intranasal immunization of adults with low titres of anti-haemagglutinin and anti-neuraminidase antibodies, and possessing sufficiently high immunogenicity were obtained by crossing of native parent strains and cross-reactivation techniques. It was confirmed that the cold-adapted A/Leningrad/134/17/57 (H2N2) influenza virus variant is a prospective donor of attenuation for obtaining recombinants--candidates for live influenza vaccine strains.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127928

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  2 in total

1.  Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants.

Authors:  Y Z Ghendon; F I Polezhaev; K V Lisovskaya; T E Medvedeva; G I Alexandrova; A I Klimov
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

2.  A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study.

Authors:  Raffael Nachbagauer; Florian Krammer; Randy A Albrecht
Journal:  Vaccines (Basel)       Date:  2018-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.